BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Mar 22, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ZX002: Phase III started

Zogenix began a double-blind, placebo-controlled, U.S Phase III trial to evaluate 10, 20, 30, 40 and 50 mg ZX002 in...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >